BioLine Rx(BLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BLRX BioLine Rx

Trading 04-01 11:57:52 EDT

3.00

+0.04

+1.35%

High3.13	Low2.90	Vol49.61K
Open3.06	D1 Closing2.96	Amplitude7.75%
Mkt Cap11.16M	Tradable Cap10.63M	Total Shares3.72M
T/O148.40K	T/O Rate1.40%	Tradable Shares3.54M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"BLRX","market":"US","secType":"STK","nameCN":"BioLine Rx","latestPrice":3,"timestamp":1743522807868,"preClose":2.96,"halted":0,"volume":49610,"delay":0,"floatShares":3543155,"shares":3721003,"eps":-10.4766,"marketStatus":"Trading","change":0.04,"latestTime":"04-01 11:57:50 EDT","open":3.06,"high":3.1295,"low":2.9,"amount":148404.59425,"amplitude":0.077534,"askPrice":2.99,"askSize":100,"bidPrice":2.94,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-10.4766,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1743537600000},"marketStatusCode":2,"adr":0,"adrRate":600,"exchange":"NASDAQ","adjPreClose":2.96,"preHourTrading":{"tag":"盘前","latestPrice":3.05,"preClose":2.96,"latestTime":"08:33 EDT","volume":10,"amount":30.5,"timestamp":1743510811891},"postHourTrading":{"tag":"盘后","latestPrice":3.04,"preClose":2.96,"latestTime":"19:04 EDT","volume":1805,"amount":5627.6573,"timestamp":1743462276634},"volumeRatio":4.863215,"impliedVol":0.2718,"impliedVolPercentile":0.052},"requestUrl":"/m/hq/s/BLRX","defaultTab":"news","newsList":[{"id":"2524927465","title":"BioLine RX Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2524927465","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524927465?lang=en_us&edition=full_marsco","pubTime":"2025-04-01 00:38","pubTimestamp":1743439080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BLRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 31, 2025 12:38 ET (16:38 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2523835921","title":"BioLine RX Ltd : H.c. Wainwright Adjusts Target Price to $26 From $9 to Reflect 1-for-40 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2523835921","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523835921?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 23:29","pubTimestamp":1743434998,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nFWN3QE16S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BLRX"],"gpt_icon":0},{"id":"2523891791","title":"Options Volatility and Implied Earnings Moves Today, March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523891791","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523891791?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:05","pubTimestamp":1743419105,"startTime":"0","endTime":"0","summary":"Today, several major companies are expected to report earnings: Bioline RX Ltd Sponsored ADR (BLRX), Red Cat Holdings (RCAT), Microvast Holdings (M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-today-march-31-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-today-march-31-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLRX","BK4603","BK4157","BK4139","RCAT"],"gpt_icon":0},{"id":"2523917158","title":"Options Volatility and Implied Earnings Moves This Week, March 31 – April 03, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917158","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917158?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:00","pubTimestamp":1743418828,"startTime":"0","endTime":"0","summary":"This week, several major companies will be reporting earnings. Among them are BlackBerry (BB), Bioline RX Ltd Sponsored ADR (BLRX), Nano-X Imaging ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-this-week-march-31-april-03-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/options-volatility-and-implied-earnings-moves-this-week-march-31-april-03-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BLRX","BK4097","BK4196","BK4609","NNOX","BK4139","BK4547"],"gpt_icon":0},{"id":"2523917611","title":"Press Release: BioLineRx Reports 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2523917611","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523917611?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 19:00","pubTimestamp":1743418800,"startTime":"0","endTime":"0","summary":"- Reports meaningful progress in the evaluation of assets for potential in-licensing and development in the areas of oncology and rare diseases -. - Executed license agreement with Ayrmid Pharma Ltd. for APHEXDA  with $10 million upfront payment, up to $87 million in commercial milestones, and high double-digit royalties on net sales -. - Completed financings raising combined gross proceeds of $19 million and reduced operating expense run rate by 70%, extending the Company's cash runway through H2 2026 -. - Management to host conference call today, March 31 , at 8:30 am EDT -. TEL AVIV, Israel, March 31, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results for the year ended December 31, 2024, and provided a corporate update.tumors, and across all territories except Asia- Licen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4136","BLRX","SCD","BK4139","ASH","BK4588","BK4022","IP","R","LU2463526074.USD","BK4232","LU1487256676.USD","LU1481600234.SGD","LU1481599808.USD","BK4109","IE00B3T34201.USD","BK4585"],"gpt_icon":0},{"id":"2523915166","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2523915166","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523915166?lang=en_us&edition=full_marsco","pubTime":"2025-03-31 18:00","pubTimestamp":1743415200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DARE","TTGT","LPRO","AMC","FC","BK4178","PRGS","BW","OMER","RDUS","BK4023","BK4086","PROK","WPRT","BK4200","SLP","AYI","SGML","RANI","BK4007","APOG","BK4584","LOAR","BHST","SPWH","ANGO","FTCI","LU0054578231.USD","BK4167","CELC","PVH","PENG","BK4141","NNOX","PVLA","BLRX","BK4524","LNN","REKR","RH","SPIR","UNF","MSM","LNZA","LW","CUK","GWH","NCNO","CAG"],"gpt_icon":0},{"id":"2522579890","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522579890","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522579890?lang=en_us&edition=full_marsco","pubTime":"2025-03-28 20:39","pubTimestamp":1743165547,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 31 for the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB0XM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2522329609","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2522329609","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522329609?lang=en_us&edition=full_marsco","pubTime":"2025-03-27 18:00","pubTimestamp":1743069600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·INmune Bio Inc.                                 4Q      (.55)  4:05 PM. ·TD SYNNEX Corp                                   1Q      2.91   8:05 AM","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNZA","KYTX","INMB","UNCY","SKYH","BHST","RANI","PVH","SLRN","SPWH","CRDL","RLMD","FC","INR","SGML","NUTX","PVLA","BCAB","GOVX","BW","GEVO","WGO","WBA","EDAP","ANGO","ADCT","CELC","NCNO","FEMY","MDAI","REKR","PENG","TSAT","FBIO","CALC","BLRX","CLSD","BRZE","IKT","TLSI","FTCI","ATAI","GWH","AFMD","NNOX","SDST","LULU","PRGS","WKSP","DARE"],"gpt_icon":0},{"id":"2521174636","title":"BioLineRx to Report 2024 Annual Results on March 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2521174636","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521174636?lang=en_us&edition=full_marsco","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Management to Hold Conference Call at 8:30 a.m. EDT. TEL AVIV, Israel, March 24, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced that it will release its audited financial results for the year ended December 31, 2024 on Monday, March 31, 2025, before the U.S. markets open.The Company will host a conference call at 8:30 a.m. EDT featuring remarks by Philip Serlin, Chief Executive Officer.To access the conference call, please dial +1-888-281-1167 from the U.S. or +972-3-918-0685 internationally. A live webcast and a replay of the call can be accessed through the event pageon the Company's website. Please allow extra time prior to the call to visit the site and download any necessary software to listen to the live broadcast. A replay of the call will be available approximately two hours after completion of the live conference call. A dial-in replay of the call will be availabl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/biolinerx-report-2024-annual-results-110000681.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biolinerx-report-2024-annual-results-110000681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BLRX"],"gpt_icon":0},{"id":"2520439968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439968?lang=en_us&edition=full_marsco","pubTime":"2025-03-20 18:00","pubTimestamp":1742464800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Amprius Tech Inc                                4Q      (.11)  4:05 PM. ·Lands' End Inc.                                   4Q       .57   6:45 AM. ·Lennar Corp Class A                              1Q      1.70       AMC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JEF","RUM","FBRX","KLC","TH","LEN","TELA","NKTX","JKS","MNSO","MLKN","FLUX","SPRY","CELC","TITN","LVTX","SKYE","PL","SLS","OUST","SBS","RLMD","SOWG","MGNX","ACRV","NKE","GDEV","COYA","DRI","BCAB","WOR","CMC","CURV","MBRX","BRAG","PAYX","LPTX","MREO","IFRX","THRD","CDLR","CBUS","DERM","ALUR","BRNS","ASO","BBNX","BLRX"],"gpt_icon":1},{"id":"2520014059","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2520014059","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520014059?lang=en_us&edition=full_marsco","pubTime":"2025-03-19 19:12","pubTimestamp":1742382742,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 21 (estima","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250319:nL8N3Q20U3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2519082968","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2519082968","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519082968?lang=en_us&edition=full_marsco","pubTime":"2025-03-14 19:50","pubTimestamp":1741953020,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 18 (estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250314:nL8N3PX0YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2517486434","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2517486434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517486434?lang=en_us&edition=full_marsco","pubTime":"2025-03-07 19:42","pubTimestamp":1741347740,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 10 (estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250307:nL5N3PQ0T6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2514323608","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514323608","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514323608?lang=en_us&edition=full_marsco","pubTime":"2025-02-28 20:05","pubTimestamp":1740744352,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on March 4 (estimat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ12A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2514098175","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514098175","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514098175?lang=en_us&edition=full_marsco","pubTime":"2025-02-25 20:02","pubTimestamp":1740484965,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on February 27 (est","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL5N3PG10A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2513426192","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2513426192","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513426192?lang=en_us&edition=full_marsco","pubTime":"2025-02-21 20:03","pubTimestamp":1740139389,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on February 24 (est","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL5N3PC0Y4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2512100202","title":"BLRX: Aphexda Transition Progressing","url":"https://stock-news.laohu8.com/highlight/detail?id=2512100202","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512100202?lang=en_us&edition=full_marsco","pubTime":"2025-02-19 17:16","pubTimestamp":1739956560,"startTime":"0","endTime":"0","summary":"BioLineRx Ltd.  continues its commercialization transition activities for Aphexda as responsibilities for marketing shift from BioLine’s internal team to Ayrmid’s subsidiary Gamida Cell. Gamida cell is commercializing Omisirge, a cell therapy for treating blood cancers in patients who need a stem cell transplant. There is substantial overlap between prospects at the target hospitals and centers for Omisirge and Aphexda, providing a natural synergy between the two assets. Now that a couple months have passed since the announcement of the arrangement, management is updating shareholders with a letter from the CEO.On January 6th, 2025, BioLineRx announced a $10 million registered direct offering. Adjusted f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/blrx-aphexda-transition-progressing-091600019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BLRX","BK4139"],"gpt_icon":0},{"id":"2512156039","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2512156039","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512156039?lang=en_us&edition=full_marsco","pubTime":"2025-02-18 20:02","pubTimestamp":1739880179,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on February 20 (est","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nL5N3P90UG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2511866067","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2511866067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511866067?lang=en_us&edition=full_marsco","pubTime":"2025-02-14 21:15","pubTimestamp":1739538908,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on February 17 (est","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250214:nL8N3P516O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":0},{"id":"2509555288","title":"BioLine RX Ltd  expected to post a loss of 93 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2509555288","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509555288?lang=en_us&edition=full_marsco","pubTime":"2025-02-05 20:46","pubTimestamp":1738759567,"startTime":"0","endTime":"0","summary":"BioLine RX Ltd  expected to post a loss of93cents a share - Earnings Preview BioLine RX Ltd BLRX.OQ, BLRX.O is expected to show a rise in quarterly revenue when it reports  results on February 7 (esti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nL8N3OW1OL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLRX"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.biolinerx.com","stockEarnings":[{"period":"1week","weight":-0.1345},{"period":"1month","weight":-0.1164},{"period":"3month","weight":-0.6542},{"period":"6month","weight":-0.8586},{"period":"1year","weight":-0.9339},{"period":"ytd","weight":-0.6542}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0586},{"period":"3month","weight":-0.0455},{"period":"6month","weight":-0.0166},{"period":"1year","weight":0.0694},{"period":"ytd","weight":-0.0455}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"BioLineRx Ltd., a commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company's pipeline includes APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It also develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.068634},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.044107},{"month":3,"riseRate":0.214286,"avgChangeRate":-0.096578},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.047194},{"month":5,"riseRate":0.538462,"avgChangeRate":0.061857},{"month":6,"riseRate":0.384615,"avgChangeRate":-0.023898},{"month":7,"riseRate":0.538462,"avgChangeRate":0.03754},{"month":8,"riseRate":0.357143,"avgChangeRate":-0.055743},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.016762},{"month":10,"riseRate":0.357143,"avgChangeRate":-0.013928},{"month":11,"riseRate":0.285714,"avgChangeRate":-0.057325},{"month":12,"riseRate":0.357143,"avgChangeRate":-0.060525}],"exchange":"NASDAQ","name":"BioLine Rx","nameEN":"BioLine Rx"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioLine Rx(BLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioLine Rx(BLRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioLine Rx,BLRX,BioLine Rx股票,BioLine Rx股票老虎,BioLine Rx股票老虎国际,BioLine Rx行情,BioLine Rx股票行情,BioLine Rx股价,BioLine Rx股市,BioLine Rx股票价格,BioLine Rx股票交易,BioLine Rx股票购买,BioLine Rx股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioLine Rx(BLRX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioLine Rx(BLRX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}